AzurRx BioPharma - Q2 2020

NASDAQ: AZRX

SEARCH

About
Science & Technology
Investors
- - Back
  - Press Releases
    
    Back
    
    2021
    
    2020
    
    2019
    
    2018
    
    2017
    
    2016
    
    2015
    
    2014
  - Events
  - Presentations
  - Regulatory Filings
  - Financial Statements
    
    Back
    
    2020
    
    Back
    
    Q2 2020
    
    Q1 2020
    
    2019
    
    Back
    
    Q4 2019
    
    Q3 2019
    
    Q2 2019
    
    Q1 2019
    
    2018
    
    Back
    
    Q4 2018
    
    Q3 2018
    
    Q2 2018
    
    Q1 2018
    
    2017
    
    Back
    
    Q4 2017
    
    Q3 2017
    
    Q2 2017
    
    Q1 2017
    
    2016
    
    Back
    
    Q4 2016
    
    Q3 2016
  - Stock Info
  - Analyst Coverage
  - Corporate Governance
  - Contact Us
News and Media
Clinical Trials
Collaborations
- - Back
  - Partnering with AzurRx
Contact

Home
Investors
Financial Statements
2020
Q2 2020

Menu

Press Releases
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Events
Presentations
Regulatory Filings
Financial Statements
- 2020
  - Q2 2020
  - Q1 2020
- 2019
- 2018
- 2017
- 2016
  - Q4 2016
  - Q3 2016
Stock Info
Analyst Coverage
Corporate Governance
Contact Us

Financial Statements

Full PDF XBRL files

Q2 2020 Financial Statement

Balance Sheet
Income Statement
Cash Flow

About
Science & Technology
Investors
News and Media
Clinical Trials
Collaborations
Contact

Contact Us

AzurRx BioPharma, Inc.

1615 South Congress Avenue
Suite 103
Delray Beach, Florida 33445

Tel: 646-699-7855
info@azurrx.com

AzurRx SAS

Jardin des Entreprises, Bat 1
290, Chemin de Saint-Dionisy
30980 Langlade, France

Tel: +33 (0)4 66 67 08 16

SiteMap Ⓒ 2021 AzurRx All Rights Reserved.